PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.\', \'Department of Family Medicine, Western University Schulich School of Medicine and Dentistry, London, Ontario, Canada.\', \'Ipsos Healthcare, Ipsos, New York, New York, USA.\', \'SMX, Ipsos, Chicago, Illinois, USA.\', \'Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada sharris1@uwo.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2021-049782
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 34475174
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all